Archives
- 2018-07
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
- 2025-09
-
TCEP Hydrochloride: Redefining Protein Assay Sensitivity ...
2025-09-26
Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride), a water-soluble reducing agent, is pushing the boundaries of protein assay sensitivity and selectivity. This in-depth analysis unveils advanced mechanistic insights and strategic applications distinct from existing reviews.
-
X-press Tag Peptide: Precision Tools for Post-Translation...
2025-09-25
Explore how X-press Tag Peptide, a leading N-terminal leader peptide, enables advanced studies of post-translational modifications in recombinant protein expression. Discover its unique role in affinity purification, detection, and experimental design strategies that go beyond standard protocols.
-
PD 0332991 (Palbociclib) HCl: Unraveling CDK4/6 Inhibitio...
2025-09-24
Explore how PD 0332991 (Palbociclib) HCl, a selective CDK4/6 inhibitor, not only induces cell cycle G1 phase arrest but also interfaces with novel mitochondrial apoptotic pathways. This article offers an advanced perspective on Palbociclib’s mechanistic depth and its implications for breast cancer and multiple myeloma research.
-
Enhancing RNA Probe Design: HyperScribe T7 High Yield Cy5...
2025-09-23
Explore the scientific advantages of the HyperScribe T7 High Yield Cy5 RNA Labeling Kit for in vitro transcription RNA labeling and fluorescent RNA probe synthesis, with an in-depth look at its applications in gene expression analysis and advanced hybridization techniques.
-
Besides its multiple peripheral effects adiponectin may amel
2025-03-03
Besides its multiple peripheral effects adiponectin may ameliorate insulin resistance by acting in the brain, and intracerebroventricular administration of adiponectin in rodents decreases body weight by stimulating energy expenditure [13]. Adiponectin most likely crosses the blood-CSF-barrier (BCB)
-
AMPK is a serine threonine protein kinase
2025-03-03
AMPK is a serine/threonine protein kinase composed of a catalytic α subunit with the activating phosphorylation site (Thr172) and two regulatory subunits, β and γ. The two AMPK variants, α1 and α2, show different cellular localization in mammalian cells. AMPKα2 is detected in nuclear and non-nuclear
-
The cellular mechanism underlying the CGS mediated
2025-03-03
The cellular mechanism underlying the CGS12066-mediated inhibition of glutamate release from hippocampal nerve terminals through presynaptic 5-HT1B receptors remains to be elucidated. 5-HT1B receptors are coupled to PTX-sensitive G proteins (Gi or Go) that have been shown to inhibit AC activity as w
-
br Aberrantly enhanced adenosine signaling
2025-03-03
Aberrantly enhanced adenosine signaling in retina of oxygen-induced retinopathy Current therapeutic development of ROP focuses on directly targeting VEGF and HIF-1α signaling pathway (Cavallaro et al., 2014, Penn et al., 2008, Mintz-Hittner et al., 2011, Hartnett and Penn, 2012). However, cellula
-
Toxicity is the main reason for the failure at
2025-03-03
Toxicity is the main reason for the failure at all stages of the new drug development process. The major part of safety-related attrition occurs at preclinical phases while predicting preclinical safety liabilities earlier in the drug development process. This strategy enables the design and/or sele
-
On another hand pyrazoles are widely found as the
2025-03-03
On another hand, pyrazoles, are widely found as the core structure in a large variety of compounds of great biological and pharmaceutical value exhibiting anti-HCV [11], antitumor [12], cytotoxic[13], and antioxidant activities [14]. Finally, 1,2,3-triazoles have attracted the interest of medicinal
-
A review has recently been published to evaluate the potenti
2025-03-03
A review has recently been published to evaluate the potential effects of food, alcohol and AH 7614 juices on the pharmacokinetics and pharmacodynamics of the drugs for BPH. The authors reviewed the PubMed database during the years 1991–2015. In addition, a digital version of Stockley on drug inter
-
br Aurora A Aurora B and Aurora C
2025-03-03
Aurora-A, Aurora-B and Aurora-C small molecule inhibitors Nicholas et al. described phenotypic cellular screening of new highly potent and selective class of Aurora kinase inhibitors. Fragment based approach was utilized; core structure of 57 (Fig. 5) was optimized and selective inhibitor 58 (Fig
-
br Experimental section br Acknowledgements br Introduction
2025-03-01
Experimental section Acknowledgements Introduction DJ-1 is a highly conserved, homodimeric protein that was originally cloned as an oncogene capable of transforming Tariquidar methanesulfonate, hydrate in cooperation with activated ras[1]. DJ-1 is over-expressed in multiple tumor types and
-
By contrast with a plenty of our understanding on arginine
2025-03-01
By fak inhibitor with a plenty of our understanding on arginine metabolism in animals and higher plants, very little thus far is known on the specific function of arginase that acts as a key control point for keeping arginine balance in edible mushrooms and neither for its physiological role in pos
-
The MOB and AOB are important in ungulates
2025-03-01
The MOB and AOB are important in ungulates (Keller and Levy, 2012, Sanchez-Andrade and Kendrick, 2009), which rely heavily on odorant information for social interactions (Baum and Cherry, 2015, Keller and Levy, 2012, Osada et al., 2014, Villagran and Ungerfeld, 2013). The release of GABA and glutama